Haoxi Health Enters Private Placement Agreement

Ticker: HAO · Form: 6-K · Filed: Oct 17, 2025 · CIK: 1954594

Haoxi Health Technology LTD 6-K Filing Summary
FieldDetail
CompanyHaoxi Health Technology LTD (HAO)
Form Type6-K
Filed DateOct 17, 2025
Risk Levelmedium
Pages1
Reading Time2 min
Key Dollar Amounts$0.0025, $1.2 million
Sentimentneutral

Sentiment: neutral

Topics: private-placement, capital-raise, securities

TL;DR

Haoxi Health inked a private placement deal with non-US investors on Oct 13, 2025. Details TBD.

AI Summary

On October 13, 2025, Haoxi Health Technology Limited entered into a securities purchase agreement (SPA) with certain non-U.S. investors for a private placement. The filing does not disclose the specific dollar amounts or terms of this private placement, only that it involves the sale of securities.

Why It Matters

This filing indicates Haoxi Health is raising capital through a private placement, which could impact its financial structure and future operations.

Risk Assessment

Risk Level: medium — Private placements can be complex and may involve risks related to investor terms, dilution, and future liquidity.

Key Players & Entities

FAQ

What type of securities are being sold in the private placement?

The filing does not specify the type of securities being sold in the private placement, only that a securities purchase agreement was entered into.

What is the total dollar amount of the private placement?

The filing does not disclose the specific dollar amounts involved in the private placement.

Who are the specific non-U.S. investors involved in the agreement?

The filing refers to 'certain 'non-U.S.' investors' but does not name them specifically.

What are the key terms and conditions of the securities purchase agreement?

The filing states that a securities purchase agreement was entered into but does not detail its specific terms and conditions.

When is the closing date for this private placement?

The filing does not mention a closing date for the private placement.

Filing Stats: 448 words · 2 min read · ~1 pages · Grade level 13 · Accepted 2025-10-17 17:25:23

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Haoxi Health Technology Limited Date: October 17, 2025 By: /s/ Zhen Fan Name: Zhen Fan Title: Chief Executive Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing